Published in Gastroenterology on November 01, 2005
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66
Impaired gastric accommodation and its role in dyspepsia. Gut (2006) 1.31
Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol (2010) 1.24
Esophageal sensation and esophageal hypersensitivity - overview from bench to bedside. J Neurogastroenterol Motil (2010) 1.15
Irritable bowel syndrome is associated with gastroesophageal reflux symptom but not erosive esophagitis. J Neurogastroenterol Motil (2013) 1.13
Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management. J Neurogastroenterol Motil (2012) 1.12
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11
Functional brain imaging of gastrointestinal sensation in health and disease. World J Gastroenterol (2007) 1.10
The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol (2013) 1.09
Pathophysiological and psychosocial study in patients with functional vomiting. J Neurogastroenterol Motil (2010) 1.06
Prevalence and risk factors of irritable bowel syndrome in healthy screenee undergoing colonoscopy and laboratory tests. J Neurogastroenterol Motil (2010) 1.02
Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia. J Gastroenterol (2012) 0.99
Oxytocin-immunoreactive innervation of identified neurons in the rat dorsal vagal complex. Neurogastroenterol Motil (2011) 0.94
Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience (2007) 0.93
Satiety testing: ready for the clinic? World J Gastroenterol (2008) 0.92
Effects of Kampo on functional gastrointestinal disorders. Biopsychosoc Med (2014) 0.91
Impact of sleep disorders, quality of life and gastric emptying in distinct subtypes of functional dyspepsia in Japan. J Neurogastroenterol Motil (2013) 0.89
The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One (2011) 0.89
Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans. Neurogastroenterol Motil (2007) 0.87
Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. Compr Physiol (2014) 0.86
Perfectionism underlying psychological background correlated with the symptoms of functional dyspepsia. J Gastroenterol (2008) 0.83
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. World J Gastroenterol (2012) 0.82
Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in women. BMC Psychiatry (2013) 0.82
Impact of eating attitude and impairment of physical quality of life between tertiary clinic and primary clinic functional dyspepsia outpatients in Japan. J Neurogastroenterol Motil (2014) 0.81
Relationship of gastrointestinal symptoms and psychosocial distress to gastric retention in children. J Pediatr (2014) 0.81
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. Am J Gastroenterol (2016) 0.77
Are there any differences in sleep disorder, quality of life and gastric motility among subtypes of functional dyspepsia? J Neurogastroenterol Motil (2013) 0.75
Tolerable pain reduces gastric fundal accommodation and gastric motility in healthy subjects: a crossover ultrasonographic study. Biopsychosoc Med (2017) 0.75
Relationship of body weight with gastrointestinal motor and sensory function: studies in anorexia nervosa and obesity. BMC Gastroenterol (2017) 0.75
The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial. Arthritis Res Ther (2016) 0.75
A family caregiver's relaxation enhances the gastric motility function of the patient: a crossover study. Biopsychosoc Med (2015) 0.75
Intravenous Corticotropin-releasing Hormone Administration Increases Esophageal Electrical Sensitivity in Healthy Individuals. J Neurogastroenterol Motil (2017) 0.75
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA (2004) 22.38
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med (2011) 6.76
Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry (2007) 6.46
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
Cross-national epidemiology of DSM-IV major depressive episode. BMC Med (2011) 4.52
Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol (2011) 3.69
Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys. Br J Psychiatry (2010) 3.38
Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology (2012) 3.35
The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms. Am J Gastroenterol (2004) 3.25
Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry (2011) 3.01
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol (2013) 2.98
Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry (2009) 2.85
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol (2005) 2.68
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66
Visualizing out-of-body experience in the brain. N Engl J Med (2007) 2.44
Status gelasticus after temporal lobectomy: ictal FDG-PET findings and the question of dual pathology involving hypothalamic hamartomas. Epilepsia (2005) 2.43
Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry (2008) 2.35
Treatment of suicidal people around the world. Br J Psychiatry (2011) 2.34
Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut (2013) 2.26
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol (2013) 2.21
Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care (2002) 2.20
Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol (2009) 2.10
Pro: Impedance testing is useful in the management of GERD. Am J Gastroenterol (2009) 2.09
Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med (2014) 2.05
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol (2003) 2.04
Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol (2004) 2.01
Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res (2004) 1.88
Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety (2010) 1.85
Reproducibility and agreement of pharyngeal automated impedance manometry with videofluoroscopy. Clin Gastroenterol Hepatol (2011) 1.84
Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. J Clin Psychiatry (2007) 1.84
Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care (2003) 1.82
A novel method for the nonradiological assessment of ineffective swallowing. Am J Gastroenterol (2011) 1.81
Dissociation in posttraumatic stress disorder: evidence from the world mental health surveys. Biol Psychiatry (2012) 1.80
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A (2007) 1.73
Parietal representation of symbolic and nonsymbolic magnitude. J Cogn Neurosci (2003) 1.70
Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc Natl Acad Sci U S A (2011) 1.69
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol (2006) 1.67
Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology (2004) 1.66
The role of criterion A2 in the DSM-IV diagnosis of posttraumatic stress disorder. Biol Psychiatry (2010) 1.60
Population level of unmet need for mental healthcare in Europe. Br J Psychiatry (2007) 1.60
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry (2007) 1.60
Nerve activity recordings in routine human intestinal biopsies. Gut (2012) 1.59
Regional brain activation during proximal stomach distention in humans: A positron emission tomography study. Gastroenterology (2005) 1.58
Defining the role of cholecystokinin in the lipid-induced human brain activation matrix. Gastroenterology (2010) 1.58
Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol (2005) 1.56
The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. J Psychiatr Res (2009) 1.55
Longitudinal microPET imaging of brain glucose metabolism in rat lithium-pilocarpine model of epilepsy. Exp Neurol (2009) 1.52
Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion (2002) 1.51
Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol (2013) 1.50
Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol (2004) 1.50
Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry (2008) 1.49
Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology (2007) 1.48
The relation between multiple pains and mental disorders: results from the World Mental Health Surveys. Pain (2007) 1.46
DSM-IV personality disorders in the WHO World Mental Health Surveys. Br J Psychiatry (2009) 1.46
Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol (2005) 1.44
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain (2008) 1.41
The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol (2007) 1.41
Childhood adversities as risk factors for onset and persistence of suicidal behaviour. Br J Psychiatry (2010) 1.40
Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med (2006) 1.35
A method to objectively assess swallow function in adults with suspected aspiration. Gastroenterology (2011) 1.35
[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction? Eur J Nucl Med Mol Imaging (2003) 1.35
Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology (2006) 1.33
Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut (2011) 1.32
Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut (2009) 1.31
Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp (2011) 1.31
Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 1.29
Relationship between anxiety and gastric sensorimotor function in functional dyspepsia. Psychosom Med (2007) 1.28
Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology (2002) 1.28
Reduced reward learning predicts outcome in major depressive disorder. Biol Psychiatry (2012) 1.28
Cumulative traumas and risk thresholds: 12-month PTSD in the World Mental Health (WMH) surveys. Depress Anxiety (2013) 1.28
Characterization of pinhole SPECT acquisition geometry. IEEE Trans Med Imaging (2003) 1.27
Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res (2004) 1.26
Human brain regions involved in visual categorization. Neuroimage (2002) 1.23
Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur J Hum Genet (2003) 1.23
Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET. Neuroimage (2004) 1.21
Dyspepsia: organic versus functional. J Clin Gastroenterol (2012) 1.20
Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood. J Psychiatr Res (2013) 1.20
The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain (2003) 1.19
Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology (2003) 1.17
Reducing loss of image quality because of the attenuation artifact in uncorrected PET whole-body images. J Nucl Med (2002) 1.17
A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol (2011) 1.17
Reduced specificity of autobiographical memory: a mediator between rumination and ineffective social problem-solving in major depression? J Affect Disord (2005) 1.17
Anxiety and mood disorders in otorhinolaryngology outpatients presenting with dizziness: validation of the self-administered PRIME-MD Patient Health Questionnaire and epidemiology. Gen Hosp Psychiatry (2003) 1.16
Food: the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am (2011) 1.15
Comparison between MAP and postprocessed ML for image reconstruction in emission tomography when anatomical knowledge is available. IEEE Trans Med Imaging (2005) 1.15
Colonic transit time and IBS symptoms: what's the link? Am J Gastroenterol (2012) 1.14